Campath, Chemo and/or TBI Allo SCT [clinicaltrials_resource:ccbc8998ce07cb79dbd63a6d1e2fb16f]
intervention [clinicaltrials_vocabulary:intervention]
Campath, Chemo and/or TBI Allo SCT [clinicaltrials_resource:ccbc8998ce07cb79dbd63a6d1e2fb16f]
Bio2RDF identifier
ccbc8998ce07cb79dbd63a6d1e2fb16f
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ccbc8998ce07cb79dbd63a6d1e2fb16f
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
Allogeneic PBSC/marrow will be ...... urrent institutional practice.
intervention name [clinicaltrials_vocabulary:intervention-name]
Campath, Chemo and/or TBI Allo SCT
other name [clinicaltrials_vocabulary:other-name]
Alemtuzumab
identifier
clinicaltrials_resource:ccbc8998ce07cb79dbd63a6d1e2fb16f
title
Campath, Chemo and/or TBI Allo SCT
@en
type
label
Campath, Chemo and/or TBI Allo ...... c8998ce07cb79dbd63a6d1e2fb16f]
@en